(Q72079848)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

T Keränen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A Gordin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M Karlsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

K Korpela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

P J Pentikäinen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

H Rita

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

E Schultz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

L Seppälä

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

T Wikberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

151-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199880

23 October 2019

exact match

0 references

cites work

Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine

1 reference

12 December 2020

A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples

1 reference

12 December 2020

Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patients

1 reference

12 December 2020

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

12 December 2020

Catechol-O-methyl transferase: pharmacological aspects and physiological role

1 reference

12 December 2020

Purification and Properties of a Catechol-O-Methyltransferase of Human Liver

1 reference

12 December 2020

Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats

1 reference

12 December 2020

The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers

1 reference

12 December 2020

Identification of major metabolites of the catechol-O-methyltransferase inhibitor entacapone in rats and humans

1 reference

12 December 2020

Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors

1 reference

12 December 2020

Parkinsonism treated with 3-O-methyldopa

1 reference

12 December 2020

Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone

1 reference

12 December 2020

3-O-methyldopa and the response to levodopa in Parkinson's disease

1 reference

12 December 2020

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

1 reference

12 December 2020

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

1 reference

12 December 2020

3-o-methyldopa inhibits rotations induced by levodopa in rats after unilateral destruction of the nigrostriatal pathway.

1 reference

12 December 2020

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

1 reference

12 December 2020

Catechol-O-methyltransferase activity in human and rat small intestine

1 reference

12 December 2020

3-O-methyldopa blocks dopa metabolism in rat corpus striatum.

1 reference

12 December 2020

Human erythrocyte catechol-o-methyltransferase: Correlation with lung and kidney activity

1 reference

12 December 2020

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

1 reference

12 December 2020

Determination of catechol-O-methyltransferase activity in erythrocytes by high performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics of levodopa and on cardiovascular responses in patients with Parkinson's disease

1 reference

12 December 2020

Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion

1 reference

12 December 2020

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

1 reference

12 December 2020

Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum

1 reference

12 December 2020

Effects of 3-OM-dopa on monoamine metabolism in rat brain

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199880

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8039535%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference